Identification of a fibronectin-binding protein signature associated with idiopathic pulmonary fibrosis.

Autor: Sun Y; Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA., King B; Leads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Hamlin AJ; Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA., Saniepay M; Leads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Gorshkov K; Leads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Barker G; Leads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Ziegler M; Leads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Mukundan S; Leads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Cvijic ME; Leads Discovery and Optimization, Bristol Myers Squibb, Lawrenceville, NJ 08648, USA., Schwarzbauer JE; Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Jazyk: angličtina
Zdroj: Cells & development [Cells Dev] 2024 Sep; Vol. 179, pp. 203941. Date of Electronic Publication: 2024 Jul 20.
DOI: 10.1016/j.cdev.2024.203941
Abstrakt: The extracellular matrix (ECM) is a critical component of tissue where it provides structural and signaling support to cells. Its dysregulation and accumulation lead to fibrosis, a major clinical challenge underlying many diseases that currently has little effective treatment. An understanding of the key molecular initiators of fibrosis would be both diagnostically useful and provide potential targets for therapeutics. The ECM protein fibronectin (FN) is upregulated in fibrotic conditions and other ECM proteins depend on assembly of a FN foundational ECM for their matrix incorporation. We used cell culture and in vivo models to investigate the role of FN in the progression of lung fibrosis. We confirmed that normal human lung fibroblasts (NHLFs) treated with transforming growth factor-beta (TGF-β) to stimulate fibrotic gene expression significantly increased both FN expression and its assembly into a matrix. We found that levels of alternatively spliced EDA and EDB exons were proportional to the increase in total FN RNA and protein showing that inclusion of these exons is not enhanced by TGF-β stimulation. RNA-sequencing identified 43 core matrisome genes that were significantly up- or down-regulated by TGF-β treatment and a Luminex immunoassay demonstrated increased levels of ECM proteins in conditioned medium of TGF-β-treated NHLFs. Interestingly, among the regulated core matrisome genes, 16 encode known FN-binding proteins and, of these, insulin-like growth factor binding protein 3 (IGFBP3) was most highly up-regulated. To link the NHLF results with in vivo disease, we analyzed lung tissue and bronchoalveolar lavage fluid from bleomycin-treated mice and found dramatically higher levels of FN and the FN-binding proteins IGFBP3, tenascin-C, and type I collagen in fibrotic conditions compared to controls. Altogether, our data identify a set of FN-binding proteins whose upregulation is characteristic of IPF and suggest that FN provides the foundational matrix for deposition of these proteins as fibrosis develops.
Competing Interests: Declaration of competing interest None.
(Copyright © 2024 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: